TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12699051

Group type: EXPERIMENTAL
Intervention: Brushing and rinsing with an essential oil‐containing mouthrinse (BEO group)
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Brushing and flossing (BF group)
Number of subjects: 326

Group type: COMPARATOR
Intervention: Brushing and rinsing with a control rinse (B group)
Number of subjects: 326
Study: 10755496

Group type: EXPERIMENTAL
Intervention: Dexfenfluramine
Number of subjects: 1473

Group type: EXPERIMENTAL
Intervention: Phentermine/fenfluramine
Number of subjects: 1473

Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 1473

Group type: EXPERIMENTAL
Intervention: Dexfenfluramine and phentermine/fenfluramine
Number of subjects: 1473
Study: 8751743

Group type: EXPERIMENTAL
Intervention: Vitamin E (alpha‐tocopherol) 200 mg daily by mouth for 3 months
Number of subjects: 15
Study: 1413198

Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 60
Study: 3933889

Group type: EXPERIMENTAL
Intervention: MMC plus canopy
Number of subjects: 0
Study: 28560503

Group type: EXPERIMENTAL
Intervention: Diet supplemented with an additional 480 g of fruit and vegetables and 300 ml of fruit juice daily for 12 weeks
Number of subjects: 45

Group type: COMPARATOR
Intervention: Usual diet (control group)
Number of subjects: 45
Study: 26728182

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical vagal nerve stimulation (t-VNS) and deep slow breathing (DSB)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 18
Study: 25044127

Group type: EXPERIMENTAL
Intervention: Luseogliflozin (SGLT2 inhibitor)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control not specified
Number of subjects: 0
Study: 22150569

Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri ATCC 55730 enema (10^10 CFU) for 8 weeks
Number of subjects: 40
Study: 20598855

Group type: EXPERIMENTAL
Intervention: High-protein, arginine- and micronutrient-enriched oral nutritional supplement (ONS)
Number of subjects: 43
Study: 18052564

Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg once daily
Number of subjects: 327

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 327
Study: 16140220

Group type: EXPERIMENTAL
Intervention: Chronic bronchitis patients
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 68
Study: 12297206

Group type: EXPERIMENTAL
Intervention: Alpha-ketoglutarate enriched enteral nutrition (n = 11)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard whole-protein-based enteral nutrition (n = 9)
Number of subjects: 20
Study: 10488999

Group type: EXPERIMENTAL
Intervention: H-wave therapy (HWT)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 48
Study: 8888163

Group type: EXPERIMENTAL
Intervention: Respiratory rehabilitation (exercise training for at least 4 weeks)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (no rehabilitation)
Number of subjects: 14
Study: 1998627

Group type: EXPERIMENTAL
Intervention: Rocket spatula
Number of subjects: 533

Group type: COMPARATOR
Intervention: Ayre spatula
Number of subjects: 533
Study: 6151741

Group type: EXPERIMENTAL
Intervention: Bopindolol 1 mg
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Bopindolol 2 mg
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg
Number of subjects: 33

Group type: COMPARATOR
Intervention: Atenolol 50 mg
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Bopindolol
Number of subjects: 33
Study: 31296113

Group type: EXPERIMENTAL
Intervention: APA-Stroke
Number of subjects: 76

Group type: COMPARATOR
Intervention: Sittercise
Number of subjects: 76
Study: 29551618

Group type: EXPERIMENTAL
Intervention: Oral quetiapine 400 mg daily (maintenance treatment)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Placebo (early treatment discontinuation)
Number of subjects: 178
Study: 26882318

Group type: EXPERIMENTAL
Intervention: Rotigotine + levodopa
Number of subjects: 967

Group type: COMPARATOR
Intervention: Placebo + levodopa
Number of subjects: 967
Study: 23180371

Group type: EXPERIMENTAL
Intervention: 10 ml 1% lidocaine injection
Number of subjects: 48

Group type: COMPARATOR
Intervention: Saline injection
Number of subjects: 48
Study: 21958882

Group type: EXPERIMENTAL
Intervention: Carotid artery stenting (CAS)
Number of subjects: 2502

Group type: COMPARATOR
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 2502

Group type: EXPERIMENTAL
Intervention: Periprocedural stroke
Number of subjects: 2502

Group type: EXPERIMENTAL
Intervention: Periprocedural myocardial infarction (MI)
Number of subjects: 2502

Group type: EXPERIMENTAL
Intervention: Periprocedural cranial nerve palsy
Number of subjects: 2502
Study: 19333156

Group type: EXPERIMENTAL
Intervention: oxymorphone ER
Number of subjects: 140

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 140
Study: 17034640

Group type: EXPERIMENTAL
Intervention: Exenatide
Number of subjects: 549

Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 549
Study: 15522048

Group type: EXPERIMENTAL
Intervention: SPECT perfusion imaging
Number of subjects: 30
Study: 11493853

Group type: EXPERIMENTAL
Intervention: Wearing a back belt
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Wearing a back belt while lifting large boxes
Number of subjects: 28
Study: 9165656

Group type: EXPERIMENTAL
Intervention: Hyperinsulinemia
Number of subjects: 0
Study: 8335427

Group type: EXPERIMENTAL
Intervention: benazepril a.m. (10 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: benazepril p.m. (10 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 10
Study: 3561954

Group type: EXPERIMENTAL
Intervention: Subconjunctival cefotaxime 100 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Intramuscular cefotaxime 1000 mg
Number of subjects: 30
Study: 28627862

Group type: EXPERIMENTAL
Intervention: Wearable devices for upper limb rehabilitation (15 daily sessions at least three times a week for 5 weeks)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Wearable devices for upper limb rehabilitation
Number of subjects: 18

Group type: COMPARATOR
Intervention: Conventional rehabilitation (control group)
Number of subjects: 18
Study: 27514445

Group type: EXPERIMENTAL
Intervention: Expanded polytetrafluoroethylene stent graft
Number of subjects: 275

Group type: COMPARATOR
Intervention: Balloon angioplasty (PTA)
Number of subjects: 275
Study: 24796057

Group type: EXPERIMENTAL
Intervention: Electric acupuncture stimulator (needle-retaining group)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Patient controlled intravenous analgesia (analgesia-pumper group)
Number of subjects: 90

Group type: COMPARATOR
Intervention: No analgesia (control group)
Number of subjects: 90
Study: 22703865

Group type: EXPERIMENTAL
Intervention: Behavioral weight loss intervention (7% mean weight loss at 6 months)
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: Behavioral weight loss intervention (6% mean weight loss at 12 months)
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: Behavioral weight loss intervention
Number of subjects: 344
Study: 20403941

Group type: EXPERIMENTAL
Intervention: Alcohol beverage (0.4 g/kg)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control beverage (nonalcoholic)
Number of subjects: 28
Study: 18256140

Group type: EXPERIMENTAL
Intervention: Aspirin 75 mg/day
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Clopidogrel 98 mg/day
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Aspirin 75 mg/day (26-h delay)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (26-h delay)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: ACh iontophoresis
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Postocclusive hyperemia
Number of subjects: 9
Study: 19727071

Group type: EXPERIMENTAL
Intervention: Oral GLP-1 (2 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (no GLP-1)
Number of subjects: 16
Study: 16107222

Group type: EXPERIMENTAL
Intervention: Procalcitonin-guided antibiotic therapy
Number of subjects: 600

Group type: COMPARATOR
Intervention: Standard antibiotic therapy
Number of subjects: 600
Study: 12215552

Group type: EXPERIMENTAL
Intervention: (186)Re-etidronate
Number of subjects: 111
Study: 9609801

Group type: EXPERIMENTAL
Intervention: Microgravity (0 G head‐to‐foot acceleration)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Postflight day 1 measurements
Number of subjects: 5
Study: 7928150

Group type: EXPERIMENTAL
Intervention: Breast conserving treatment (BCT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Narrow marginal tumor excision with aggressive radiation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Wide resection with a small dose of radiation
Number of subjects: 0
Study: 3145375

Group type: EXPERIMENTAL
Intervention: Early postoperative enteral alimentation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Total parenteral alimentation
Number of subjects: 0
Study: 11449182

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol therapy (TTS) 50 mg/day for 6 months
Number of subjects: 362

Group type: COMPARATOR
Intervention: Control group (untreated subjects)
Number of subjects: 362
Study: 30948560

Group type: EXPERIMENTAL
Intervention: Home food gardening intervention (receiving 2 years of support designing, installing and maintaining a home food garden of at least 80 square feet)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Home food gardening intervention
Number of subjects: 100

Group type: COMPARATOR
Intervention: Delayed-intervention control (receiving same gardening support after 2 years of data collection)
Number of subjects: 100
Study: 30289357

Group type: EXPERIMENTAL
Intervention: Societal-gain frame
Number of subjects: 299

Group type: COMPARATOR
Intervention: Societal-loss frame
Number of subjects: 299
Study: 26086897

Group type: EXPERIMENTAL
Intervention: Transcutaneous interferential electrical stimulation (IFES) + standard urotherapy
Number of subjects: 36

Group type: COMPARATOR
Intervention: Standard urotherapy
Number of subjects: 36
Study: 25456811

Group type: EXPERIMENTAL
Intervention: TMCP training
Number of subjects: 31

Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 31
Study: 22592761

Group type: EXPERIMENTAL
Intervention: Intracavernosal injection (ICI) with 30-60 mg papaverine
Number of subjects: 25

Group type: COMPARATOR
Intervention: Sildenafil 100 mg
Number of subjects: 25

Group type: COMPARATOR
Intervention: Tadalafil 20 mg
Number of subjects: 25
Study: 19853678

Group type: EXPERIMENTAL
Intervention: Risedronate, 35 mg once weekly (RIS)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 67
Study: 17697972

Group type: EXPERIMENTAL
Intervention: BU4 (0.8 mg/kg, over 2 hours 4 times a day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: BU1 (3.2 mg/kg, over 3 hours once a day)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: BU4
Number of subjects: 60

Group type: COMPARATOR
Intervention: BU1
Number of subjects: 60
Study: 16145317

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol (50 microg/day) continuously and transdermal norethisterone (250 microg/day for 14 days of every 28‐day cycle)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control group (95 women with viral chronic hepatitis but without climacteric symptoms)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol and norethisterone
Number of subjects: 81
Study: 11879884

Group type: EXPERIMENTAL
Intervention: Blinding (double blind)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Blinding (not specified)
Number of subjects: 0
Study: 10424412

Group type: EXPERIMENTAL
Intervention: Visual feedback during passive motion reproduction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Passive motion reproduction without visual feedback
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Different velocity profiles (constant, sinusoidal, complex) during passive displacements
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2AFC task for distance discrimination
Number of subjects: 0
Study: 7778464

Group type: EXPERIMENTAL
Intervention: 6% carbohydrate solution with 7 g L‐1 of branched‐chain amino acids (BCAA)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: 6% carbohydrate solution (CHO)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Flavoured water
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: CHO + BCAA
Number of subjects: 5

Group type: COMPARATOR
Intervention: CHO alone
Number of subjects: 5
Study: 2113590

Group type: EXPERIMENTAL
Intervention: Mitomycin C instillation
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: Doxorubicin instillation
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: Combination of long-term and short-term instillation protocols
Number of subjects: 419

Group type: COMPARATOR
Intervention: Short-term instillation protocols
Number of subjects: 419

Group type: COMPARATOR
Intervention: Long-term instillation protocols
Number of subjects: 419
Study: 104342

Group type: EXPERIMENTAL
Intervention: 10 mg of oral amphetamine sulfate
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 25 mg of oral anileridine dihydrochloride
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Combination of amphetamine and anileridine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 24
Study: 31556580

Group type: EXPERIMENTAL
Intervention: In vitro fertilization (IVF)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Spontaneous conception (SC)
Number of subjects: 158
Study: 30974395

Group type: EXPERIMENTAL
Intervention: Robotic Gait Training (RGT) program three times a week for 12 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard physiotherapy rehabilitation (PTR) program three days a week for 12 weeks
Number of subjects: 24
Study: 28380213

Group type: EXPERIMENTAL
Intervention: MCAO+RA group
Number of subjects: 216

Group type: COMPARATOR
Intervention: MCAO+vehicle group
Number of subjects: 216

Group type: COMPARATOR
Intervention: sham‐operated group
Number of subjects: 216
Study: 27215809

Group type: EXPERIMENTAL
Intervention: Mineral Trioxide Aggregate (MTA)
Number of subjects: 260

Group type: COMPARATOR
Intervention: Super Ethoxybenzoic Acid (Super EBA)
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Overall success rate
Number of subjects: 260

Group type: COMPARATOR
Intervention: Comparison of MTA and Super EBA
Number of subjects: 260

Group type: COMPARATOR
Intervention: Comparison of follow-up periods
Number of subjects: 260
Study: 25052724

Group type: EXPERIMENTAL
Intervention: Spironolactone 25 mg/d
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study: 21940392

Group type: EXPERIMENTAL
Intervention: Lymphatic staining method
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control unstained group
Number of subjects: 62
Study: 19421321

Group type: EXPERIMENTAL
Intervention: Glutamine (0.5 g/kg/d)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 17205318

Group type: EXPERIMENTAL
Intervention: Nicotine lozenges
Number of subjects: 145

Group type: COMPARATOR
Intervention: Placebo lozenges
Number of subjects: 145
Study: 15068500

Group type: EXPERIMENTAL
Intervention: Raloxifene (60 or 120 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15675639

Group type: EXPERIMENTAL
Intervention: Word context benefit at the fovea
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Word context benefit at the periphery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Manipulated interletter spacing
Number of subjects: 0
Study: 11889743

Group type: EXPERIMENTAL
Intervention: Study mattress (advanced, non-powered, air and foam surface)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Low-air-loss mattress
Number of subjects: 20
Study: 9781971

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 1153

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1153
Study: 7949022

Group type: EXPERIMENTAL
Intervention: Radiotherapy
Number of subjects: 8
Study: 3064191

Group type: EXPERIMENTAL
Intervention: Combined modality treatment (radiotherapy and chemotherapy)
Number of subjects: 227

Group type: COMPARATOR
Intervention: No adjuvant therapy
Number of subjects: 227

Group type: COMPARATOR
Intervention: Chemotherapy only
Number of subjects: 227

Group type: COMPARATOR
Intervention: Radiotherapy only
Number of subjects: 227
Study: 29658764

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Mediation as Usual (MAU)
Number of subjects: 177
Study: 28094135

Group type: EXPERIMENTAL
Intervention: VA‐DPP
Number of subjects: 387

Group type: COMPARATOR
Intervention: MOVE!
Number of subjects: 387
Study: 26674253

Group type: EXPERIMENTAL
Intervention: Dark chocolate (DC) 40 g daily
Number of subjects: 9

Group type: COMPARATOR
Intervention: White chocolate (WC)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Baseline (BL)
Number of subjects: 9
Study: 24092978

Group type: EXPERIMENTAL
Intervention: Rivastigmine 18 mg patch with domperidone 30 mg (RWD)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Rivastigmine 18 mg patch without domperidone (RWOD)
Number of subjects: 30
Study: 21466595

Group type: EXPERIMENTAL
Intervention: Risedronate (RIS) 35 mg/week plus calcium 1000 mg/day and vitamin D(3) 800 IU/day
Number of subjects: 89

Group type: COMPARATOR
Intervention: Calcium 1000 mg/day and vitamin D(3) 800 IU/day
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 89
Study: 18809520

Group type: EXPERIMENTAL
Intervention: Entropy-guided anesthesia
Number of subjects: 65

Group type: COMPARATOR
Intervention: Conventional anesthesia
Number of subjects: 65
Study: 16410062

Group type: EXPERIMENTAL
Intervention: Ledermix
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Septomixine
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Calasept
Number of subjects: 88
Study: 12627187

Group type: EXPERIMENTAL
Intervention: Increased folate intake through diet and supplement (400 microg folic acid)
Number of subjects: 126
Study: 10853164

Group type: EXPERIMENTAL
Intervention: Epidural corticosteroid injection (100 mg methylprednisolone in 10 mL bupivacaine 0.25%)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no epidural corticosteroid injection)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Epidural corticosteroid injection
Number of subjects: 36
Study: 8966823

Group type: EXPERIMENTAL
Intervention: Prenatal exposure to phenobarbital
Number of subjects: 114

Group type: COMPARATOR
Intervention: Control group (unexposed men)
Number of subjects: 114
Study: 1556404

Group type: EXPERIMENTAL
Intervention: 1,200 mg Mg(OH)2
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 2,400 mg Mg(OH)2
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 3,600 mg Mg(OH)2
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Mg(OH)2 (all doses)
Number of subjects: 6
Study: 3890497

Group type: EXPERIMENTAL
Intervention: Ketotifen
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 30321900

Group type: EXPERIMENTAL
Intervention: Classical Massage Therapy (KMT)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Acupuncture Therapy (AKU)
Number of subjects: 132
Study: 30379867

Group type: EXPERIMENTAL
Intervention: Indoor housing with protection from heat stress
Number of subjects: 581

Group type: EXPERIMENTAL
Intervention: Pasture access with heat stress
Number of subjects: 581

Group type: COMPARATOR
Intervention: Indoor housing with heat stress
Number of subjects: 581

Group type: EXPERIMENTAL
Intervention: Pasture access with protection from heat stress
Number of subjects: 581
Study: 27179722

Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 6000

Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 6000
Study: 25098587

Group type: EXPERIMENTAL
Intervention: Insert (two-page, evidence-based article)
Number of subjects: 179833

Group type: EXPERIMENTAL
Intervention: Outsert (short, directive message stapled to the newsletter)
Number of subjects: 179833

Group type: EXPERIMENTAL
Intervention: Both insert and outsert
Number of subjects: 179833

Group type: EXPERIMENTAL
Intervention: Both insert, outsert, and patient reminder
Number of subjects: 179833

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 179833
Study: 23151294

Group type: EXPERIMENTAL
Intervention: Turned implants (Tur)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Moderately rough implants (TiUnite, TiU)
Number of subjects: 14
Study: 19465191

Group type: EXPERIMENTAL
Intervention: Emulsified fish oil
Number of subjects: 10

Group type: COMPARATOR
Intervention: Capsular triglyceride fish oil
Number of subjects: 10
Study: 17469883

Group type: EXPERIMENTAL
Intervention: Telephone-based cognitive-behavioral therapy (CBT) plus care management
Number of subjects: 393
Study: 15281999

Group type: EXPERIMENTAL
Intervention: Coasted group
Number of subjects: 78

Group type: COMPARATOR
Intervention: Non-coasted group
Number of subjects: 78
Study: 12215984

Group type: EXPERIMENTAL
Intervention: Ropivacaine 2.0 mg/mL
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ropivacaine 5.0 mg/mL
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ropivacaine 7.5 mg/mL
Number of subjects: 30
Study: 10412335

Group type: EXPERIMENTAL
Intervention: Environmental controls (wrapping mattress with vinyl cover, washing bedding with hot water every two weeks, removal of soft furniture, wet cleaning bedroom floor daily)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 30
Study: 7734555

Group type: EXPERIMENTAL
Intervention: Curled catheter
Number of subjects: 72

Group type: COMPARATOR
Intervention: Straight catheter
Number of subjects: 72
Study: 1706024

Group type: EXPERIMENTAL
Intervention: Dietary protein intake
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Animal protein intake
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Dietary sodium intake
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Dietary potassium intake
Number of subjects: 96
Study: 6264292

Group type: EXPERIMENTAL
Intervention: Acyclovir
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 6464626

Group type: EXPERIMENTAL
Intervention: Postoperative treatment with nasogastric tubes
Number of subjects: 97

Group type: COMPARATOR
Intervention: Postoperative treatment without nasogastric tubes
Number of subjects: 97
Study: 30206369

Group type: EXPERIMENTAL
Intervention: S-1 plus cisplatin (SP arm)
Number of subjects: 108

Group type: COMPARATOR
Intervention: vinorelbine plus cisplatin (VP arm)
Number of subjects: 108